查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1776695

2032 年女性科技市场预测：按类型、功能、应用、最终用户和地区进行的全球分析

FemTech Market Forecasts to 2032 - Global Analysis By Type, Functional Capability, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球女性科技市场预计在 2025 年达到 480.5 亿美元，到 2032 年将达到 1,564.8 亿美元，预测期内的复合年增长率为 18.37%。

Femtech 是「女性科技」的缩写，指的是一系列旨在促进女性健康和福祉的产品、服务、诊断和软体。该行业提供各种各样的解决方案，包括用于追踪月经的应用程式、用于管理更年期的工具、生育和妊娠监测设备，以及为患有慢性疾病、心理健康问题和性健康问题的人提供支援的线上资源。此外，由于人们对性别特定医疗保健需求的认识不断提高，女性科技正在帮助缩小医疗保健领域的性别数据差距，并增强女性的个人化照护。

根据世界经济论坛的数据，光是九种疾病就占了女性数据和照护健康差距的三分之一，但从 2019 年到 2023 年，它们获得的累积研究资金不到 1%。缩小这些差距可以在 2040 年前每年节省 2700 万个残疾调整生命年，并产生 1 兆美元的全球 GDP。

提升妇女健康知识

近期，全球发生了一场文化变革，一些过去被污名化或忽视的女性健康问题，例如月经、更年期、不孕症问题和生育权利，如今正被公开讨论并优先考虑。现今的女性更积极主动监测月经週期、管理经前症候群 (PMS) 症状、儘早解决不孕症问题，并寻求针对卵巢症候群 (PCOS) 和子宫内膜异位症等长期疾病的专门治疗。此外，女性健康组织、社群媒体影响力人士和教育宣传活动是提升女性意识的关键驱动力。因此，对能够提供诊断、资讯和支援的女性科技解决方案的需求日益增长。

标准和法规不明确

缺乏法律规范是女性科技产业面临的最大问题之一，尤其是在穿戴式感测器、行动应用程式和基于人工智慧的诊断等数位健康产品方面。许多国家对于特定女性科技产品究竟属于健康工具或医疗设备存在不确定性，这会影响产品分类、核准流程和合规标准。这项监管灰色地带可能会阻碍创新、限制市场进入并阻碍投资，尤其对于那些缺乏资源来应对复杂法律环境的新兴企业而言。此外，由于各国标准不一，导致成长分散，全球企业发展也面临挑战。

探索更年期与中年健康

中老年女性一直以来都未被充分重视，如今她们正成为女性科技产业的关键消费族群。每年有数百万女性进入更年期和闭经，这增加了她们对潮热、失眠、荷尔蒙失衡和心理问题等症状的解决方案的需求。这群人通常愿意为改善寿命和生活品质的健康和保健服务付费。此外，开发荷尔蒙补充疗法或人工智慧驱动的症状追踪平台等专业产品的女性科技企业可以扩大规模，并吸引那些通常富有的忠实客户。

网路安全与资料外洩风险

中老年女性一直以来都未被充分重视，如今她们正成为女性科技产业的关键消费族群。每年有数百万女性进入更年期和闭经，这增加了她们对潮热、失眠、荷尔蒙失衡和心理问题等症状的解决方案的需求。这群人通常愿意为改善寿命和生活品质的健康和保健服务付费。此外，开发荷尔蒙补充疗法平台和人工智慧辅助症状追踪等专业产品的女性科技企业可以接触到这个不断扩大、积极参与且通常富裕的客户群。

COVID-19的影响：

新冠疫情对女性科技市场产生了双重影响，既加速了成长，也带来了挑战。一方面，一些女性科技产品（尤其是基于硬体的解决方案）的初期应用受到了供应链中断、临床试验延迟以及面对面医疗服务受限等因素的阻碍。另一方面，远端医疗、经期追踪应用、生育监测工具以及女性专属心理健康平台的使用率均因疫情而有所增长，显着加速了数位化医疗的发展趋势。由于传统医疗服务因社交隔离措施而关闭和受限，女性转向数位化解决方案来管理她们的情绪、生殖和怀孕健康。因此，女性科技领域的投资和用户参与度激增。

预计在预测期内，监控和追踪部分将成长至最大的部分。

预计监测和追踪领域将在预测期内占据最大的市场占有率。此类别包括穿戴式科技、数位平台和行动应用程序，使女性能够监测排卵、月经週期、生育能力、怀孕情况、更年期症状和一般健康指标。女性科技的主导地位源自于对预防性和个人化照护日益增长的需求、人们对女性健康议题的认识不断提高，以及穿戴式装置和智慧型手机的普及率不断提高。此外，女性科技产业高度依赖监测和追踪，因为这些工具使女性能够掌控自己的健康状况，及早发现异常，并在无需持续临床干预的情况下做出明智的决策。

预计预测期内怀孕和护理部门的复合年增长率最高。

预计孕产妇护理领域将在预测期内实现最高成长率。随着孕产妇健康意识的不断提高，以及穿戴式胎儿分娩监视器、数位怀孕追踪应用程式、远距医疗平台和产后护理解决方案的日益普及，该行业的爆炸式增长正在加速。越来越多的女性开始使用科技工具来即时了解胎儿发育、营养、运动、心理健康和母乳哺育支持等资讯。职业母亲人数的增加、远端医疗服务覆盖率的扩大以及部分地区生育率的上升，都推动了该领域的需求成长。这些因素共同支撑了该领域强劲的年复合成长率，并使其在女性科技发展方向中发挥关键作用。

比最大的地区

由于人们对女性健康问题的强烈关注、高智慧型手机普及率以及先进的数位基础设施，预计北美将在预测期内占据最大的市场占有率。美国凭藉其蓬勃发展的女性科技Start-Ups生态系统、强大的资金筹措以及支持数位健康创新的创业投资框架，在该地区其他国家中脱颖而出。不断上涨的医疗成本和自我管理预防保健的趋势，导致对更年期管理工具、生育护理解决方案和生育追踪应用程式的需求不断增长。此外，保险公司和职场健康倡议越来越多地提供女性科技产品，进一步巩固了该地区的市场主导地位。

复合年增长率最高的地区：

在预测期内，亚太地区预计将实现最高的复合年增长率，这得益于数位医疗基础设施投资的增加、互联网和智慧型手机普及率的提高以及女性健康意识的不断增强。在中国、印度、日本和韩国等国家，尤其是在都市区和精通科技的人群中，行动医疗应用程式、生育治疗解决方案和孕产妇护理平台的需求旺盛。该地区的快速成长也得益于政府为改善女性获得医疗保健的机会所采取的倡议，以及该地区女性科技新兴企业的崛起。随着医疗保健产业的快速数位化，亚太地区正成为全球女性科技产业的关键成长引擎。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章 全球女性科技市场（按类型）

  • 装置
    • 穿戴式装置
    • 诊断设备
  • 软体
    • 月经健康应用
    • 生育治疗/辅助生殖技术应用程式
    • 怀孕和产后护理应用程式
    • 更年期管理应用程式
    • 通用女性健康与保健应用程式
  • 服务
    • 远端医疗和虚拟护理
    • 咨询和支援服务
    • 基于订阅的健康服务
    • 平台化服务

第六章 全球女性科技市场（按功能）

  • 诊断
  • 监控和追踪
  • 治疗/干预
  • 健康教育和意识
  • 咨询/远端医疗

第七章 全球女性科技市场（按应用）

  • 怀孕和哺乳
  • 生殖健康与避孕
  • 月经健康
  • 一般健康
  • 骨盆腔和子宫健康
  • 性健康和保健
  • 更年期护理
  • 心理和情绪健康
  • 肿瘤学
  • 其他用途

第八章 全球女性科技市场（依最终用户）

  • 直接面向消费者
  • 医院
  • 手术中心
  • 不孕不育诊所
  • 诊断中心
  • 其他最终用户

9. 全球女性科技市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Google, Inc
  • Apple, Inc
  • Sirona Hygiene Private Limited
  • Glow, Inc
  • BioWink GmbH
  • Natural Cycles USA Corp
  • Athena Feminine Technologies
  • Flo Health, Inc.
  • HeraMed
  • iSono Health, Inc.
  • Chiaro Technology Limited
  • Joylux, Inc.
  • Nuvo Inc.
  • FemTec Health Inc
  • Simple Health Inc
Product Code: SMRC30026

According to Stratistics MRC, the Global FemTech Market is accounted for $48.05 billion in 2025 and is expected to reach $156.48 billion by 2032 growing at a CAGR of 18.37% during the forecast period. FemTech, short for "female technology," is a term used to describe an expanding range of products, services, diagnostics, and software aimed at promoting the health and well-being of women. This industry offers a broad range of solutions, such as apps for tracking menstruation, tools for managing menopause, fertility and pregnancy monitoring devices, and online resources for supporting people with chronic illnesses, mental health issues, and sexual health. Moreover, FemTech is helping to bridge the gender data gap in medicine and enhance women's individualized care as a result of growing awareness of gender-specific healthcare needs.

According to the World Economic Forum, only nine conditions account for one-third of women's health gaps in data and care-but together these received less than 1% of cumulative research funding between 2019 and 2023. Closing these gaps could unlock 27 million DALYs each year and generate $1 trillion in global GDP by 2040.

Market Dynamics:

Driver:

Growing knowledge of women's health concerns

A global cultural shift has occurred recently toward the open discussion and prioritization of women's health issues that were previously stigmatized or disregarded, including menstruation, menopause, fertility issues, and reproductive rights. Today's women are more proactive in monitoring their cycles, controlling the symptoms of PMS, addressing infertility early, and seeking professional treatment for long-term conditions like polycystic ovary syndrome (PCOS) and endometriosis. Additionally, women's health organizations, social media influencers, and education campaigns are the main drivers of this rising awareness. Consequently, there is now a greater need for FemTech solutions that provide diagnosis, information, and support.

Restraint:

Absence of standards and regulatory clarity

The lack of precise and uniform regulatory frameworks is one of the biggest issues facing the FemTech sector, particularly with regard to digital health products like wearable sensors, mobile apps, and AI-based diagnostics. There is uncertainty in many nations regarding whether specific FemTech products are considered wellness tools or medical devices, which has an impact on product classification, approval processes, and compliance standards. Especially for startups that lack the resources to handle complicated legal environments, this regulatory gray area can impede innovation, limit market access, and deter investment. Furthermore, global expansion is challenging due to disparate national standards, which results in fragmented growth.

Opportunity:

Expansion into menopause and midlife health

Midlife and older women, who have historically been underrepresented, are becoming a significant consumer segment in the FemTech industry. Every year, millions of women go through perimenopause and menopause, increasing the need for ways to deal with symptoms like hot flashes, insomnia, hormone imbalance, and mental health issues. For health and wellness services that improve longevity and quality of life, this group is frequently willing to pay. Additionally, FemTech businesses that create specialized products, such as platforms for hormone replacement therapy or AI-driven symptom tracking, can reach this expanding, devoted, and frequently wealthy clientele.

Threat:

Risks to cybersecurity and data breach

Midlife and older women, who have historically been underrepresented, are becoming a significant consumer segment in the FemTech industry. Every year, millions of women go through perimenopause and menopause, increasing the need for ways to deal with symptoms like hot flashes, insomnia, hormone imbalance, and mental health issues. For health and wellness services that improve longevity and quality of life, this group is frequently willing to pay. Additionally, FemTech businesses that create specialized products, such as platforms for hormone replacement therapy or AI-driven symptom tracking, can reach this expanding, devoted, and frequently wealthy clientele.

Covid-19 Impact:

On the FemTech market, the COVID-19 pandemic had a dual effect, serving as a growth accelerator and a challenge. From one perspective, the initial adoption of some FemTech products, particularly hardware-based solutions, was hampered by supply chain disruptions, postponed clinical trials, and limited access to in-person healthcare services. However, telemedicine, period tracking apps, fertility monitoring tools, and women-specific mental health platforms were all used more frequently as a result of the pandemic, which also greatly accelerated the trend toward digital health. As traditional care was restricted by lockdowns and social distancing, women resorted to digital solutions for managing their emotional, reproductive, and pregnancy health. This resulted in a spike in FemTech investment and user engagement.

The monitoring & tracking segment is expected to be the largest during the forecast period

The monitoring & tracking segment is expected to account for the largest market share during the forecast period. This category comprises wearable technology, digital platforms, and mobile apps that let women monitor their ovulation, menstrual cycles, fertility, pregnancy, menopause symptoms, and general health indicators. Its dominance stems from the growing demand for preventive and personalized care, the growing awareness of women's health issues, and the growing adoption of wearables and smartphones. Moreover, the FemTech industry relies heavily on monitoring & tracking because these tools enable women to take charge of their health, identify abnormalities early, and make educated decisions without continual clinical intervention.

The pregnancy and nursing care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pregnancy and nursing care segment is predicted to witness the highest growth rate. Rising maternal health awareness and the growing use of wearable fetal monitors, digital pregnancy tracking apps, remote consultation platforms, and postpartum care solutions are all contributing factors to this industry's explosive growth. For real-time insights into fetal development, nutrition, exercise, mental health, and breastfeeding support, women are increasingly using tech-enabled tools. Growing numbers of working mothers, increased telehealth access, and rising fertility rates in some areas all contribute to the demand. Additionally, these elements support the segment's robust compound annual growth rate and pivotal role in determining the direction of FemTech.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by a strong awareness of women's health issues, a high smartphone penetration rate, and sophisticated digital infrastructure. With a thriving FemTech startup ecosystem, significant venture capital funding, and supportive regulations for digital health innovations, the U.S. stands out among the other countries in the region. Rising healthcare costs and the trend toward self-managed, preventive care are contributing factors to the growing demand for menopause management tools, pregnancy care solutions, and fertility tracking apps. Moreover, FemTech products are also increasingly being offered by insurance companies and workplace wellness initiatives, which further solidify the region's leading position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by an increase in investment in digital healthcare infrastructure, a rise in internet and smartphone penetration, and a growing awareness of women's health. Mobile health apps, fertility solutions, and maternal care platforms are in high demand in countries like China, India, Japan, and South Korea, particularly among urban and tech-savvy populations. The region's rapid growth is also attributed to government initiatives to improve women's access to healthcare and the growing number of local FemTech startups. With the rapid digitization of healthcare, Asia-Pacific is becoming a major growth engine for the global FemTech sector.

Key players in the market

Some of the key players in FemTech Market include Google, Inc, Apple, Inc, Sirona Hygiene Private Limited, Glow, Inc, BioWink GmbH, Natural Cycles USA Corp, Athena Feminine Technologies, Flo Health, Inc., HeraMed, iSono Health, Inc., Chiaro Technology Limited, Joylux, Inc., Nuvo Inc., FemTec Health Inc and Simple Health Inc.

Key Developments:

In March 2025, Google LLC announced it has signed a definitive agreement to acquire Wiz, Inc., a leading cloud security platform headquartered in New York, for $32 billion, subject to closing adjustments, in an all-cash transaction. Once closed, Wiz will join Google Cloud. This acquisition represents an investment by Google Cloud to accelerate two large and growing trends in the AI era: improved cloud security and the ability to use multiple clouds.

In February 2025, Apple Inc. and Indonesia have agreed on terms to lift the country's ban on iPhone 16s, said people familiar with the matter, paving the way to end a five-month tug-of-war that forced the US tech giant to raise its promised investment in the country to $1 billion. The Ministry for Industry, which is responsible for upholding the ban, is set to sign a memorandum of agreement with Apple as soon as this week, according to people familiar with the talks, who asked not to be identified discussing private matters.

In October 2024, Flo Health has partnered with FemTech India to introduce its Pass It On Project via a special Diwali campaign. With a global base of over 80 million and 1.5 million monthly active users in India alone, Flo Health, a leading global period and ovulation tracker, is doubling down on its presence in the country. The Pass It on Project offers free Flo Premium subscriptions to women in 22 countries, where access to safe and credible health information is limited.

Types Covered:

  • Device
  • Software
  • Service

Functional Capabilities Covered:

  • Diagnostics
  • Monitoring & Tracking
  • Therapeutic/Intervention
  • Health Education & Awareness
  • Consultation/Telemedicine

Applications Covered:

  • Pregnancy and Nursing Care
  • Reproductive Health & Contraception
  • Menstrual Health
  • General Wellness
  • Pelvic & Uterine Health
  • Sexual Health & Wellness
  • Menopause Care
  • Mental Health & Emotional Wellbeing
  • Oncology
  • Other Applications

End Users Covered:

  • Direct to Consumer
  • Hospitals
  • Surgical Centers
  • Fertility Clinics
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global FemTech Market, By Type

  • 5.1 Introduction
  • 5.2 Device
    • 5.2.1 Wearable Devices
    • 5.2.2 Diagnostic Devices
  • 5.3 Software
    • 5.3.1 Menstrual Health Apps
    • 5.3.2 Fertility Management/Assisted Reproductive Technology Apps
    • 5.3.3 Pregnancy & Postpartum Care Apps
    • 5.3.4 Menopause Management Apps
    • 5.3.5 General Women's Health & Wellness Apps
  • 5.4 Service
    • 5.4.1 Telehealth & Virtual Care
    • 5.4.2 Counseling & Support Services
    • 5.4.3 Subscription Health Services
    • 5.4.4 Platform-based Services

6 Global FemTech Market, By Functional Capability

  • 6.1 Introduction
  • 6.2 Diagnostics
  • 6.3 Monitoring & Tracking
  • 6.4 Therapeutic/Intervention
  • 6.5 Health Education & Awareness
  • 6.6 Consultation/Telemedicine

7 Global FemTech Market, By Application

  • 7.1 Introduction
  • 7.2 Pregnancy and Nursing Care
  • 7.3 Reproductive Health & Contraception
  • 7.4 Menstrual Health
  • 7.5 General Wellness
  • 7.6 Pelvic & Uterine Health
  • 7.7 Sexual Health & Wellness
  • 7.8 Menopause Care
  • 7.9 Mental Health & Emotional Wellbeing
  • 7.10 Oncology
  • 7.11 Other Applications

8 Global FemTech Market, By End User

  • 8.1 Introduction
  • 8.2 Direct to Consumer
  • 8.3 Hospitals
  • 8.4 Surgical Centers
  • 8.5 Fertility Clinics
  • 8.6 Diagnostic Centers
  • 8.7 Other End Users

9 Global FemTech Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Google, Inc
  • 11.2 Apple, Inc
  • 11.3 Sirona Hygiene Private Limited
  • 11.4 Glow, Inc
  • 11.5 BioWink GmbH
  • 11.6 Natural Cycles USA Corp
  • 11.7 Athena Feminine Technologies
  • 11.8 Flo Health, Inc.
  • 11.9 HeraMed
  • 11.10 iSono Health, Inc.
  • 11.11 Chiaro Technology Limited
  • 11.12 Joylux, Inc.
  • 11.13 Nuvo Inc.
  • 11.14 FemTec Health Inc
  • 11.15 Simple Health Inc

List of Tables

  • Table 1 Global FemTech Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global FemTech Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global FemTech Market Outlook, By Device (2024-2032) ($MN)
  • Table 4 Global FemTech Market Outlook, By Wearable Devices (2024-2032) ($MN)
  • Table 5 Global FemTech Market Outlook, By Diagnostic Devices (2024-2032) ($MN)
  • Table 6 Global FemTech Market Outlook, By Software (2024-2032) ($MN)
  • Table 7 Global FemTech Market Outlook, By Menstrual Health Apps (2024-2032) ($MN)
  • Table 8 Global FemTech Market Outlook, By Fertility Management/Assisted Reproductive Technology Apps (2024-2032) ($MN)
  • Table 9 Global FemTech Market Outlook, By Pregnancy & Postpartum Care Apps (2024-2032) ($MN)
  • Table 10 Global FemTech Market Outlook, By Menopause Management Apps (2024-2032) ($MN)
  • Table 11 Global FemTech Market Outlook, By General Women's Health & Wellness Apps (2024-2032) ($MN)
  • Table 12 Global FemTech Market Outlook, By Service (2024-2032) ($MN)
  • Table 13 Global FemTech Market Outlook, By Telehealth & Virtual Care (2024-2032) ($MN)
  • Table 14 Global FemTech Market Outlook, By Counseling & Support Services (2024-2032) ($MN)
  • Table 15 Global FemTech Market Outlook, By Subscription Health Services (2024-2032) ($MN)
  • Table 16 Global FemTech Market Outlook, By Platform-based Services (2024-2032) ($MN)
  • Table 17 Global FemTech Market Outlook, By Functional Capability (2024-2032) ($MN)
  • Table 18 Global FemTech Market Outlook, By Diagnostics (2024-2032) ($MN)
  • Table 19 Global FemTech Market Outlook, By Monitoring & Tracking (2024-2032) ($MN)
  • Table 20 Global FemTech Market Outlook, By Therapeutic/Intervention (2024-2032) ($MN)
  • Table 21 Global FemTech Market Outlook, By Health Education & Awareness (2024-2032) ($MN)
  • Table 22 Global FemTech Market Outlook, By Consultation/Telemedicine (2024-2032) ($MN)
  • Table 23 Global FemTech Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global FemTech Market Outlook, By Pregnancy and Nursing Care (2024-2032) ($MN)
  • Table 25 Global FemTech Market Outlook, By Reproductive Health & Contraception (2024-2032) ($MN)
  • Table 26 Global FemTech Market Outlook, By Menstrual Health (2024-2032) ($MN)
  • Table 27 Global FemTech Market Outlook, By General Wellness (2024-2032) ($MN)
  • Table 28 Global FemTech Market Outlook, By Pelvic & Uterine Health (2024-2032) ($MN)
  • Table 29 Global FemTech Market Outlook, By Sexual Health & Wellness (2024-2032) ($MN)
  • Table 30 Global FemTech Market Outlook, By Menopause Care (2024-2032) ($MN)
  • Table 31 Global FemTech Market Outlook, By Mental Health & Emotional Wellbeing (2024-2032) ($MN)
  • Table 32 Global FemTech Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 33 Global FemTech Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 34 Global FemTech Market Outlook, By End User (2024-2032) ($MN)
  • Table 35 Global FemTech Market Outlook, By Direct to Consumer (2024-2032) ($MN)
  • Table 36 Global FemTech Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 37 Global FemTech Market Outlook, By Surgical Centers (2024-2032) ($MN)
  • Table 38 Global FemTech Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 39 Global FemTech Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 40 Global FemTech Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.